These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24253372)

  • 1. Neuroleptic malignant syndrome in an adolescent with CYP2D6 deficiency.
    Butwicka A; Krystyna S; Retka W; Wolańczyk T
    Eur J Pediatr; 2014 Dec; 173(12):1639-42. PubMed ID: 24253372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of association in Japanese patients between neuroleptic malignant syndrome and a debrisoquine 4-hydroxylase genotype with low enzyme activity.
    Kawanishi C; Furuno T; Onishi H; Sugiyama N; Suzuki K; Matsumura T; Ishigami T; Kosaka K
    Psychiatr Genet; 2000 Sep; 10(3):145-7. PubMed ID: 11204351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP2D6 gene deletion allele in patients with neuroleptic malignant syndrome: preliminary report.
    Kato D; Kawanishi C; Kishida I; Furuno T; Matsumura T; Hasegawa H; Suzuki K; Hirayasu Y
    Psychiatry Clin Neurosci; 2005 Aug; 59(4):504-7. PubMed ID: 16048458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroleptic malignant syndrome and hydroxylase gene mutations: no association with CYP2D6A or CYP2D6B.
    Kawanishi C; Hanihara T; Maruyama Y; Matsumura T; Onishi H; Inoue K; Sugiyama N; Suzuki K; Yamada Y; Kosaka K
    Psychiatr Genet; 1997; 7(3):127-9. PubMed ID: 9323326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP2D6 Hhal genotype and the neuroleptic malignant syndrome (NMS).
    Iwahashi K; Nakamura K; Suwaki H; Tsuneoka Y; Ichikawa Y
    Clin Chim Acta; 1997 Sep; 265(1):143-4. PubMed ID: 9352138
    [No Abstract]   [Full Text] [Related]  

  • 6. Mutation involving cytochrome P450IID6 in two Japanese patients with neuroleptic malignant syndrome.
    Kawanishi C; Shimoda Y; Fujimaki J; Onishi H; Suzuki K; Hanihara T; Sugiyama N; Kosaka K
    J Neurol Sci; 1998 Sep; 160(1):102-4. PubMed ID: 9804127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of CYP2D6 polymorphisms on neuroleptic malignant syndrome.
    Kato D; Kawanishi C; Kishida I; Furuno T; Suzuki K; Onishi H; Hirayasu Y
    Eur J Clin Pharmacol; 2007 Nov; 63(11):991-6. PubMed ID: 17701031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of CYP2D6 and TaqI A polymorphisms in malignant neuroleptic syndrome: two case reports with three episodes.
    Zivković M; Mihaljević-Peles A; Sagud M; Silić A; Mihanović M
    Psychiatr Danub; 2010 Mar; 22(1):112-6. PubMed ID: 20305604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].
    Askenazy F; Dor E; Benoit M; Dupuis G; Serret S; Myquel M; Seddiki Y
    Encephale; 2010 Feb; 36(1):46-53. PubMed ID: 20159196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYP2D6 HhaI genotype and the neuroleptic malignant syndrome.
    Iwahashi K; Yoshihara E; Nakamura K; Ameno K; Watanabe M; Tsuneoka Y; Ichikawa Y; Igarashi K
    Neuropsychobiology; 1999; 39(1):33-7. PubMed ID: 9892857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroleptic malignant syndrome associated with the use of prochlorperazine in a patient with a recent history of antipsychotic-induced neuroleptic malignant syndrome.
    Musselman ME; Browning LA; Parker D; Saely S
    Ann Pharmacother; 2011 Nov; 45(11):e61. PubMed ID: 21972252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ziprasidone- and lithium-induced neuroleptic malignant syndrome.
    Borovicka MC; Bond LC; Gaughan KM
    Ann Pharmacother; 2006 Jan; 40(1):139-42. PubMed ID: 16352776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A study of neuroleptic malignant syndrome in the presenium and senium].
    Suzuki I; Honma H; Watanabe N; Matsubara S; Koyama T
    Seishin Shinkeigaku Zasshi; 1998; 100(6):387-97. PubMed ID: 9745353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroleptic malignant syndrome: a review and report of six cases.
    Kasantikul D; Kanchanatawan B
    J Med Assoc Thai; 2006 Dec; 89(12):2155-60. PubMed ID: 17214072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic malignant syndrome due to olanzapine.
    Hall KL; Taylor WH; Ware MR
    Psychopharmacol Bull; 2001; 35(3):49-54. PubMed ID: 12397878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Case report: Neuroleptic malignant syndrome and diagnostic difficulties].
    Khouri C; Planès S; Logerot S; Villier C; Mallaret M
    Encephale; 2016 Jun; 42(3):277-80. PubMed ID: 26923996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S; Kornreich C; Choubani Z; Gourevitch R
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuroleptic malignant syndrome: case report with recurrence associated with the use of olanzapine].
    Hanel RA; Sandmann MC; Kranich M; De Bittencourt PR
    Arq Neuropsiquiatr; 1998 Dec; 56(4):833-7. PubMed ID: 10029891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olanzapine-associated neuroleptic malignant syndrome.
    Norgard NB; Stark JE
    Pharmacotherapy; 2006 Aug; 26(8):1180-2. PubMed ID: 16863495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic malignant syndrome in pregnancy: case report and literature review.
    Escobar-Vidarte MF; Loaiza-Osorio S; Messa AA; Macías GE
    J Matern Fetal Neonatal Med; 2019 Jul; 32(14):2438-2441. PubMed ID: 29363376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.